• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow
Which psychedelic company will win the match on mental health treatments?

Which psychedelic company will win the match on mental health treatments?

by EmpathiCSubstanceS | Nov 9, 2021 | Psychedelic Medicine

New results from a clinical trial using MDMA to treat post-traumatic stress disorder showed the promise of a stigmatized drug to treat mental illness at a time when Covid-19 has raised global awareness of the toll of mental health conditions. Companies like Compass...
Which psychedelic company will win the match on mental health treatments?

Who’s fighting to save psychedelic treatments for PTSD?

by EmpathiCSubstanceS | Nov 9, 2021 | Neuropathy, NN-Dimethyltryptamine

learn how the chemical psilocybin, found in psychedelic drugs, can potentially help people who have PTSD, and discuss the ethical implications of using drugs that are often used recreationally as therapeutics. Curriculum Integration Ideas This tool may be used in life...
Which psychedelic company will win the match on mental health treatments?

What should the new psychedelic treatment be for anxiety?

by EmpathiCSubstanceS | Nov 9, 2021 | Psychotropics

In what’s been described as a ‘paradigm shifter’ for psychiatry, Australian clinical trials are exploring the therapeutic benefits of illegal substances. It was out of desperation that Michael Raymond found himself sitting in a remote retreat in the Peruvian Andes,...
Which psychedelic company will win the match on mental health treatments?

What level of mental health professionals can practice psychedelic therapy?

by EmpathiCSubstanceS | Nov 9, 2021 | Psychotropics, San Pedro Mescaline

As recent trials of psychedelic-assisted psychotherapy enter the last phase of testing, the coming need for psychedelic training seems inevitable. The demand for many trained therapists and guides will be high. Until recently, the lone opportunity to train and work...
Which psychedelic company will win the match on mental health treatments?

What types of mental disorders can be treated with psychedelics?

by EmpathiCSubstanceS | Nov 9, 2021 | Psychedelic Medicine

Psychedelic therapy is a technique that involves the use of psychedelic substances to aid the therapeutic process. Hallucinogenic substances have been used in holistic medicine and for spiritual practices by various cultures for thousands of years. Research on the use...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

LSD enhances suggestibility in healthy volunteers

Aug 16, 2022

Volunteers gave significantly higher ratings for the CIS (p = 0.018), but not the MIT (p = 0.11), after LSD than placebo. The magnitude of suggestibility enhancement under LSD was positively correlated with trait conscientiousness measured at baseline (p = 0.0005)....

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Aug 16, 2022

LSD reduced associative, but concurrently increased sensory-somatomotor brain-wide and thalamic connectivity. Ketanserin fully blocked the subjective and neural LSD effects. Whole-brain spatial patterns of LSD effects matched 5-HT2A receptor cortical gene expression...

N,N-dimethyltryptamine and the pineal gland: Separating fact from myth.

Aug 16, 2022

It is clear that very minute concentrations of N,Ndimethyltryptamine have been detected in the brain, but they are not sufficient to produce psychoactive effects. Alternative explanations are presented to explain how stress and near death can produce altered states of...

Psychedelic Medicine

Remembering Dr. Jordi Riba, Ayahuasca Research Pioneer (1968–2020)

Nov 9, 2020

On August 14, 2020, the world bid farewell to scientific pioneer, Dr. Jordi Riba. The untimely death of the Catalan ayahuasca researcher has come as a harsh blow to the close-knit ayahuasca community the world over. Riba was undoubtedly one of the most prolific...

Compass Pathways’ Leads the Way as the First Psychedelics Company To IPO on the Nasdaq FN Media Group Presents Microsmallcap.com Market Commentary

Nov 8, 2020

NEW YORK, Sept. 24, 2020 /PRNewswire/ -- Last year may have been all about cannabis, but it's clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson's (NYSE:JNJ) ketamine-derived medicine, Spravato, received the first...

UC Berkeley launches new center for psychedelic science and education

Nov 8, 2020

Fifty years after political and cultural winds slammed shut the doors on psychedelic research, UC Berkeley is making up for lost time by launching the campus’s first center for psychedelic science and public education. With $1.25 million in seed funding from an...

Colorado’s Nowak Society Launches Public Education Campaign on Psychedelics

Nov 8, 2020

On May 7, 2019, the city of Denver made headlines for becoming the first U.S. city to effectively decriminalize psilocybin mushrooms through its passing of Initiated Ordinance 301 (I-301). In the months that followed, Oakland and Santa Cruz followed suit,...

Company Seeks to Patent Psilocybin for Weight Loss

Nov 8, 2020

Psilocybin has been fast-tracked by the FDA to become a prescription medication in psychedelic-assisted therapy for depression, but now we’re seeing investors line up to support a new indication for the synthetic compound that’s been made famous—in its organic form—by...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow